Qida raises €37M led by Quadrille to expand home care Spain

Qida has closed a significant growth round of €37 million to accelerate its push into personalised, preventive home care across Spain. The financing, led by Quadrille Capital with co-leads Asabys Partners (Sabadell Asabys II) and COFIDES, also counts participation from ICF, Endeavor Catalyst and long-standing backers such as Ship2B Ventures, Kibo Ventures and Creas.

The company says the new capital will fund product development, expand clinical and operational teams, and scale services to reach more than 100,000 older adults. Management intends to invest heavily in data-driven tools that support proactive interventions and tailor care plans—moving beyond episodic visits toward continuous, predictive care pathways.

Founded to help older people remain healthier and more independent at home, Qida is operating at the intersection of two powerful trends: Europe’s ageing population and rapid digitalisation of health and social care. Spain ranks among EU countries with a high share of residents aged 65+, and demand for in-home support is expected to rise sharply over the next decade. Market estimates point to mid-single-digit to high-single-digit annual growth for the home care segment in many Western European markets as payors and families shift care out of institutions.

Investor backing from a mix of specialised healthtech and impact-oriented funds underlines growing appetite for companies that combine clinical services with software platforms. The round also reflects a wider pattern of late-seed and growth capital flowing into startups tackling ageing and chronic-disease management. For Qida, the cash will reinforce both its field operations—home-care professionals, coordination teams—and its technology stack: remote monitoring, risk stratification and personalisation engines.

Founder and CEO Oriol Fuertes Cabassa commented that the investment brings together “leading public and private funds” aligned on improving quality of life for older people, and praised the continuity of support from early investors.

The fresh funding positions Qida to consolidate its lead in Spain but also raises the usual execution questions: hiring and retaining skilled caregivers, integrating with regional health systems, and demonstrating cost-effectiveness to public payors. Success will depend on converting technology improvements into measurable outcomes—fewer hospital admissions, reduced institutional care and improved patient-reported quality of life.